Forbes columnist Sachin Jain describes 10 new year’s resolutions to help healthcare leaders to lead better in the year 2026.
Midterm elections and surging healthcare costs are colliding in 2026. Here’s what these pressures may force politicians, insurers and drugmakers to do.
Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1 space booming, it’s now a prime M&A target for giants jostling for their share of a potential $100 billion market.
A radiologist and public health expert breaks down what we know about President Trump’s CT scan, and what this means for his health.
Differences in vaccination policies illustrate the importance of context, regarding distinct healthcare systems and the vaccine stance taken by public health officials.
Childhood vaccine schedules among U.S. peers differ marginally. Unlike the U.S., however, peer health officials don’t sow doubt among the public about vaccination.
Medicare’s cap on out-of-pocket costs helps cancer patients and others taking expensive drugs. With less financial burden, patients can better afford their medications.
FDA approval for the first brain stimulation device cleared for home use in treating depression
In this week’s edition of The Prototype we look at the biggest tech breakthroughs of 2025–and the year’s best music.
It isn’t wrong to promote healthier living. But misinforming the public on the flu vaccine and downplaying the disease’s impact aren’t in public health’s interest.